VESPER-1: the durability signal In a 32-week exploratory extension (Part B) of VESPER-1, Pfizer reports a 15.9% non-placebo-adjusted weight loss with no plateau observed at 32 weeks on 2.4 mg weekly berobenatide in participants who escalated from placebo to active drug
GLP-1 Support Protein: Formulated with 30 g of whey protein, 5 g of collagen for skin health and myHMB (TSI Group) and PeptiStrong (Nuritas) to help counteract muscle loss
Read More SVP(A)-2026-0065-FDAC || Procurement for the Supply, Delivery, Installation and Activation of Food and Drug Action Centers Firewall Appliance, License and One Year Subscription 6 July 2026 Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply, Delivery, Installation and Activation of Food and Drug Action Center's
and C.R.)
Cyanocobalamin: Common side effects may include dizziness, headache, feeling tired or weak, feeling nervous and excitable, upset stomach, diarrhea, or signs of a common cold
Its gentle yet effective formulation ensures compatibility with a wide range of skin types
